Rebound Medical Receives Growth Equity Investment from Castleford Capital

DANBURY, Connecticut—Castleford Capital (Castleford), a private equity firm focused on investing in health care and pharmaceutical services companies, announced a growth investment in Rebound Medical Systems Corp. (Rebound). Rebound provides durable medical equipment (DME) to patients recovering from orthopedic and vascular surgical procedures.

“We will use this new capital to invest in our team and drive growth in our service territories, which build upon our dedication to physicians and their patients,” said Todd Piatnik, founder of Rebound. “The entire Rebound team is excited by this new partnership. I am thankful to our employees and business partners for their years of dedication. I am very appreciative of our physician and practice clients, who have positioned us for this transformational growth opportunity.”

Rebound enables physician practices to deliver DME products and services to their patients while minimizing office resources. Rebound administers the entire process including patient insurance verification, patient education and communication, delivery of equipment, accurately and efficiently processing claims, and provider communication management. Rebound allows physician practices to provide beneficial products and services to its patients recovering from surgical procedures and managing chronic conditions related to deep vein thrombosis and lymphedema creating substantial value for patients and physicians.

“Todd and the team have built Rebound into an impressive organization,” said Jeffrey Marlough, managing director at Castleford Capital, “and we look forward to enhancing the base of services and products that help orthopedic, vascular, podiatry, pain management and spine physicians deliver the best quality of care to their patients.”

The terms of the transaction were not disclosed.